NASDAQ
Financial data for ASTH
46.72% YoY
28.93% YoY
30.00% YoY
Annual Income Statement for ASTH
| Item | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | $2B | $1B | $1B | $774M | $370M |
| Cost of Revenue | $2B | $1B | $945M | $596M | $349M |
| Gross Profit | $271M | $215M | $199M | $178M | $22M |
| Operating Expenses | $182M | $130M | $95M | $80M | $16M |
| Operating Income | $89M | $85M | $104M | $98M | $6M |
| Net Income | $43M | $61M | $45M | $69M | -$24M |
| EPS | $0.91 | $1.30 | $1.00 | $1.57 | $1.04 |
| EBITDA | $142M | $124M | $112M | $101M | $30M |
No price data available for this timeframe.